Data updated: Mar 10, 2026
AVANDIA
ROSIGLITAZONE MALEATE
Approved 1999-05-25
7
Indications
--
Phase 3 Trials
2
Priority Reviews
26
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1999-05-25
- Routes
- ORAL
- Dosage Forms
- TABLET
AVANDIA Approval History
Loading approval history...
What AVANDIA Treats
7 FDA approvalsOriginally approved for its first indication in 1999 . Covers 7 distinct patient populations.
- Other (7)
Other
(7 approvals)- • Approved indication (May 1999) PriorityLabel Letter
- • Approved indication (Apr 2000)Label Letter
- • Approved indication (Feb 2003)Label Letter
- • Approved indication (Feb 2005)Label Letter
- • Approved indication (Jul 2005) PriorityLabel Letter
- • Approved indication (Apr 2006)Label Letter
- • Approved indication (Jul 2008)Label Letter
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
AVANDIA FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.